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Abstract
Microbes within polymicrobial infections often display synergistic interactions resulting in enhanced pathogenesis;
however, the molecular mechanisms governing these interactions are not well understood. Development of model systems
that allow detailed mechanistic studies of polymicrobial synergy is a critical step towards a comprehensive understanding of
these infections in vivo. In this study, we used a model polymicrobial infection including the opportunistic pathogen
Aggregatibacter actinomycetemcomitans and the commensal Streptococcus gordonii to examine the importance of
metabolite cross-feeding for establishing co-culture infections. Our results reveal that co-culture with S. gordonii enhances
the pathogenesis of A. actinomycetemcomitans in a murine abscess model of infection. Interestingly, the ability of A.
actinomycetemcomitans to utilize L-lactate as an energy source is essential for these co-culture benefits. Surprisingly,
inactivation of L-lactate catabolism had no impact on mono-culture growth in vitro and in vivo suggesting that A.
actinomycetemcomitans L-lactate catabolism is only critical for establishing co-culture infections. These results demonstrate
that metabolite cross-feeding is critical for A. actinomycetemcomitans to persist in a polymicrobial infection with S. gordonii
supporting the idea that the metabolic properties of commensal bacteria alter the course of pathogenesis in polymicrobial
communities.
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Introduction
The survival of pathogens in the human body has been
rigorously studied for well over a century. The ability of bacteria to
colonize, persist and thrive in vivo is due to an array of capabilities
including the ability to attach to host tissues, produce extracellular
virulence factors, and evade the immune system. Invading
pathogens must also obtain carbon and energy from an infection
site, and specific carbon sources are required for several pathogens
to colonize and persist in the host [1]. Although mono-culture
infections provide interesting insight into pathogenesis, many
bacterial infections are not simply the result of colonization with a
single species, but are instead a result of colonization with several
[2,3,4,5]. The mammalian oral cavity is an excellent environment
to study polymicrobial interactions as it is persistently colonized
with diverse commensal bacteria as well as opportunistic
pathogens. Our lab has utilized a two-species model system
composed of the opportunistic pathogen Aggregatibacter actinomyce-
temcomitans and the common commensal Streptococcus gordonii to
provide mechanistic insight into how specific carbon sources
impact disease pathogenesis in polymicrobial infections [6,7].
A. actinomycetemcomitans is a Gram-negative facultative anaerobic
bacterium that inhabits the human oral cavity and is a proposed
causative agent of localized aggressive periodontitis [8]. A.
actinomycetemcomitans is found between the gums and tooth surface
in the subgingival crevice [9,10], an area restricted for O2
depending on tissue depth [11] and irrigated by a serum exudate
called gingival crevicular fluid (GCF). GCF not only contains
serum proteins such as complement and immunoglobulin [12], but
also glucose from 10 to 500 mM in healthy patients [13] and as
high as 3 mM in patients with periodontal infections [14]. L-
lactate is produced by host lactate dehydrogenase in GCF [15,16]
and resident oral streptococci. Together glucose and L-lactate
represent two of the small number of carbon sources that A.
actinomycetemcomitans is able to catabolize [17]. A. actinomycetemcomi-
tans has been proposed to primarily inhabit the aerobic [9]
‘‘moderate’’ pockets (4 to 6 mm in depth) of the gingival crevice as
opposed to deeper anaerobic subgingival pockets [18].
In addition to A. actinomycetemcomitans, the subgingival crevice is
home to a diverse bacterial population, including numerous oral
streptococci [19], that reside in surface-associated biofilm
communities [20]. Oral streptococci, aside from Streptococcus
mutans, are typically non-pathogenic and depending upon the
human subject and method of sampling, comprise approximately
5% [21] to over 60% [22] of the recoverable oral flora. Through
fermentation of carbohydrates to L-lactate and sometimes H2O2,
acetate, and CO2, oral streptococci such as S. gordonii have been
shown to influence the composition of oral biofilms [19,20,23,24].
Additionally, S. gordonii-produced H2O2 influences interactions
between A. actinomycetemcomitans and the host by inducing
production of ApiA, a factor H binding protein that inhibits
complement-mediated lysis [7,25]. Thus, streptococcal metabolites
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dynamics of oral biofilms and how oral bacteria interact with the
host.
A. actinomycetemcomitans preferentially catabolizes L-lactate over
high energy carbon sources such as glucose and fructose in
multiple strains, despite the fact that this bacterium grows more
slowly with L-lactate [6]. Given this preference for a presumably
inferior carbon source and the observation that A. actinomycetemco-
mitans resides in close association with oral streptococci [26,27], we
hypothesize an in vivo benefit exists for A. actinomycetemcomitans L-
lactate preference. To test this hypothesis, we investigated the
importance of A. actinomycetemcomitans L-lactate catabolism during
mono-culture and co-culture with S. gordonii in vitro and in a murine
abscess model of infection. Our results reveal that co-culture with
S. gordonii enhances colonization and pathogenesis of A. actinomy-
cetemcomitans, and the ability to utilize L-lactate as an energy source
is essential for these co-culture benefits. Surprisingly, inactivation
of L-lactate catabolism had no impact on mono-culture growth in
vitro and in vivo suggesting that A. actinomycetemcomitans L-lactate
catabolism is only critical for establishing co-culture infections.
Taken together, these results provide compelling mechanistic
evidence that the metabolic properties of human commensals such
as S. gordonii can alter the course of pathogenesis in polymicrobial
communities.
Results
A. actinomycetemcomitans metabolism of glucose and
L-lactate
Within the gingival crevice, host-produced glucose and L-lactate
are present [13,14,15,16,28] and likely serve as in vivo carbon
sources for A. actinomycetemcomitans. However in contrast to glucose,
L-lactate is also produced by the oral microbial flora, primarily
oral streptococci [20]. Indeed, the ability of A. actinomycetemcomitans
to catabolize streptococcal-produced L-lactate has been demon-
strated previously [6], and it was proposed that A. actinomycetemco-
mitans consumes streptococcal-produced L-lactate during co-
culture. To assess the importance of A. actinomycetemcomitans L-
lactate catabolism in polymicrobial communities in vitro,w e
examined the metabolic profile during catabolism of L-lactate
and glucose under aerobic and anaerobic conditions. Aerobically,
A. actinomycetemcomitans primarily produced lactate and acetate from
glucose (Fig. 1A) while acetate was the sole metabolite produced
by L-lactate-grown bacteria (Fig. 1C). It was intriguing that lactate
was produced, but not consumed, by A. actinomycetemcomitans during
aerobic catabolism of glucose. We hypothesized that the lactate
produced by A. actinomycetemcomitans was likely D-lactate, which is
not catabolized by A. actinomycetemcomitans [29]. Using an
enzymatic assay [30], we were able to verify that .99% of the
lactate produced by A. actinomycetemcomitans was indeed D-lactate.
Anaerobically from glucose, A. actinomycetemcomitans primarily
produced the mixed acid fermentation products formate and
acetate along with lactate, succinate, and trace amounts of ethanol
(Fig. 1B). Surprisingly, A. actinomycetemcomitans was unable to
Figure 1. Aerobic and anaerobic metabolites produced by A.
actinomycetemcomitans, A. actinomycetemcomitans lctD
- and A.
actinomycetemcomitans cydB
-. Resting cell suspensions of each
culture were incubated (A )aerobically in glucose; (B), anaerobically in
glucose; (C), aerobically or anaerobically in lactate. Metabolite
concentrations were measured by HPLC. Data in A and B is presented
as moles of metabolite produced/mole of glucose consumed. Only
trace concentrations (,50 mM) of ethanol were observed in anaerobic
suspensions. Error bars represent 1 standard error of the mean, n=3. *
Acetate concentrations are shown per mM of L-lactate consumed. The
detection limit for acetate was 100 mM.
doi:10.1371/journal.ppat.1002012.g001
Author Summary
Many bacterial infections are not the result of colonization
and persistence of a single pathogenic microbe in an
infection site but instead the result of colonization by
several. Although the importance of polymicrobial inter-
actions and pathogenesis has been noted by many
prominent microbiologists including Louis Pasteur, most
studies of pathogenic microbes have focused on single
organism infections. One of the primary reasons for this
oversight is the lack of robust model systems for studying
bacterial interactions in an infection site. Here, we use a
model co-culture system composed of the opportunistic
oral pathogen Aggregatibacter actinomycetemcomitans
and the common oral commensal Streptococcus gordonii
to assess the impact of polymicrobial growth on patho-
genesis. We found that the abilities of A. actinomycetem-
comitans to persist and cause disease are enhanced during
co-culture with S. gordonii. Remarkably, this enhanced
persistence requires A. actinomycetemcomitans catabolism
of L-lactate, the primary metabolite produced by S.
gordonii. These data demonstrate that during co-culture
growth, S. gordonii provides a carbon source for A.
actinomycetemcomitans that is necessary for establishing
a robust polymicrobial infection. This study also demon-
strates that virulence of an opportunistic pathogen is
impacted by members of the commensal flora.
Cross-Feeding in a Polymicrobial Infection
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alternative electron acceptors nitrate or dimethyl sulfoxide were
added, suggesting that L-lactate oxidation was O2 dependent. This
is distinct from other oral bacteria including members of the genus
Veillonella [24,31], in which L-lactate is an important anaerobic
carbon and energy source. If O2 respiration was indeed required
for A. actinomycetemcomitans growth with L-lactate, we hypothesized
that elimination of the terminal respiratory oxidase, which is
required for aerobic respiration, would abolish L-lactate utilization
by A. actinomycetemcomitans aerobically. To test this hypothesis, cydB,
which encodes a component of the sole putative A. actinomyce-
temcomitans respiratory oxidase, was insertionally inactivated. The
cydB mutant was unable to catabolize L-lactate aerobically
supporting the hypothesis that L-lactate oxidation requires O2
respiration (Fig. 1C). Interestingly when grown with glucose
aerobically, the cydB mutant doubled much slower (6.6 hr) than
the wt (1.9 hr) and cell suspensions produced a metabolite profile
that differed from the wt (Fig. 1A) indicating that while not
required for aerobic growth on glucose, O2 respiration is the
primary means by which glucose is catabolized by wt A.
actinomycetemcomitans. As expected, the cydB mutant exhibited
identical growth rates anaerobically on glucose (not shown) and
produced similar metabolites as the wt (Fig. 1B). Collectively, these
data indicate that O2 respiration is required for L-lactate oxidation
in A. actinomycetemcomitans.
As the ultimate goal of this study is to assess the importance of A.
actinomycetemcomitans L-lactate catabolism for establishing co-culture
with oral streptococci, it was important to assess whether
eliminating the ability of A. actinomycetemcomitans to utilize L-lactate
affected growth with glucose. To examine this, we examined
growth and metabolite production in an A. actinomycetemcomitans
strain in which the catabolic L-lactate dehydrogenase LctD, which
is present in all strains sequenced to date [32,33], was insertionally
inactivated [29]. LctD oxidizes L-lactate to pyruvate and is
required for A. actinomycetemcomitans growth with L-lactate as the
sole energy source [29]. As expected, the lctD mutant was unable
to catabolize L-lactate aerobically or anaerobically (Fig. 1C);
however, metabolite production from glucose was not affected
(Fig. 1A&B) nor was the growth rate with glucose (not shown).
These data indicate that L-lactate catabolism can be eliminated in
A. actinomycetemcomitans without affecting growth and metabolite
production with glucose.
Utilization of L-lactate enhances co-culture growth
Because A. actinomycetemcomitans preferentially catabolizes L-
lactate in lieu of hexose sugars [6], we hypothesized that L-lactate
cross-feeding was important for establishing co-culture with oral
streptococci grown on glucose. To test this hypothesis, we
examined growth of glucose-grown A. actinomycetemcomitans and S.
gordonii during in vitro co-culture aerobically and anaerobically.
Aerobically, wt A. actinomycetemcomitans co-culture cell numbers
were similar to those observed in mono-culture while the A.
actinomycetemcomitans lctD mutant exhibited an approximate 25-fold
decrease in cell number during co-culture with S. gordonii (Fig. 2).
Anaerobically, both wt A. actinomycetemcomitans and A. actinomyce-
temcomitans lctD
- cell numbers diminished nearly 10-fold in co-
culture compared to mono-culture (Fig. 2), likely due to the
inability to catabolize S. gordonii-produced L-lactate.
Examination of aerobic metabolic end products of the A.
actinomycetemcomitans lctD
-/S. gordonii co-culture revealed high levels
of lactate, reminiscent of S. gordonii mono-cultures, indicating that
as expected, the A. actinomycetemcomitans lctD mutant is unable to
catabolize L-lactate in co-culture (Fig. 3A). Additionally, metab-
olite concentrations in anaerobic co-cultures were similar to S.
gordonii mono-culture (Fig. 3B). It should be noted that these
metabolites were measured from growing cells, not cell suspensions
as in Fig. 1. These data provide strong evidence that the inability
Figure 2. Growth of A. actinomycetemcomitans, A. actinomyce-
temcomitans lctD
-, and S. gordonii in aerobic and anaerobic co-
cultures. Strains were grown as mono- or co-cultures in 3 mM glucose
aerobically or anaerobically for 10 or 12 h respectively, serially diluted
and plated on selective media to determine colony forming units per ml
(CFU/ml). A. actinomycetemcomitans mono-culture strains are black bars
and co-culture with S. gordonii are white bars. Error bars represent 1
standard error of the mean, n=3.
doi:10.1371/journal.ppat.1002012.g002
Figure 3. Metabolite production by A. actinomycetemcomitans,
A. actinomycetemcomitans lctD
-, and S. gordonii in aerobic or
anaerobic co-cultures. Supernatants of the cultures used for CFU
measurements in Fig. 2 were analyzed by HPLC for metabolite
production from (A), aerobic or (B), anaerobic cultures. Data is
presented as moles of metabolite produced/mole of glucose con-
sumed. Error bars represent 1 standard error of the mean, n=3. ND =
No Data.
doi:10.1371/journal.ppat.1002012.g003
Cross-Feeding in a Polymicrobial Infection
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A. actinomycetemcomitans growth and survival in co-culture.
Interestingly, an approximate 7-fold increase in S. gordonii cell
numbers were observed in the presence of A. actinomycetemcomitans
aerobically, indicating that A. actinomycetemcomitans enhances S.
gordonii proliferation under these co-culture conditions even when
A. actinomycetemcomitans is unable to utilize L-lactate (Fig. S1 in Text
S1). Importantly, the pH of the medium used in these experiments
remained at neutrality; thus changes in cell numbers were not due
to alterations in pH.
L-lactate consumption is required for co-culture growth
of A. actinomycetemcomitans in vivo
The observation that L-lactate catabolism is critical for A.
actinomycetemcomitans to establish co-culture with S. gordonii in vitro
provides new insight into this model polymicrobial community;
however, whether the requirement for this catabolic pathway
extended to in vivo co-culture was not known. To examine the role
of A. actinomycetemcomitans L-lactate catabolism for in vivo growth in
mono- and co-culture, we used a mouse thigh abscess model. This
model has relevance as A. actinomycetemcomitans causes abscess
infections outside of the oral cavity in close association with other
bacteria [34] and has been used as a model system to examine
pathogenesis of several oral bacteria [35,36]. Using this model,
bacterial survival and abscess formation was assessed for wt A.
actinomycetemcomitans and A. actinomycetemcomitans lctD
- during mono-
and co-culture with S. gordonii (Fig. 4).
Unexpectedly, wt A. actinomycetemcomitans and the lctD mutant
established similar infections in terms of cell number (Fig. 4A) and
in abscess weight (Fig. 4B) indicating that host-derived L-lactate is
not an important in vivo nutrient source during mono-culture
infection. Interestingly, wt A. actinomycetemcomitans displayed a 10-
fold increase in cell number when co-cultured with S. gordonii,
while cell number of the lctD mutant declined .100-fold
compared to the wild-type providing evidence that the ability to
catabolize L-lactate is crucial for A. actinomycetemcomitans co-culture
survival in vivo. These data also indicate that while not critical for
mono-culture growth, L-lactate is an important energy source
during co-culture infection. Unlike the in vitro experiments (Fig. S1
in Text S1), S. gordonii numbers were not statistically different in
monoculture or in co-culture abscesses (2.7610
7 and 1.3610
7
CFU/ml respectively; p=0.15 via Mann-Whitney test) indicating
that S. gordonii does not receive a benefit, at least in regard to cell
number, from co-culture with A. actinomycetemcomitans. As a control,
in vivo growth of the A. actinomycetemcomitans apiA mutant, which is
hypersusceptible to killing by innate immunity, was examined. As
expected, the apiA mutant exhibited a .250-fold decrease in
mono-culture in vivo survival, which was unchanged in the
presence of S. gordonii (Fig. 4A).
Discussion
Microbes within polymicrobial infections often display syner-
gistic interactions that result in enhanced colonization and
persistence in the infection site [5,34,36,37,38,39,40]. Such
interactions have been particularly noted in oral polymicrobial
infections, although the molecular processes controlling these
synergistic interactions are not well defined. Detailed mechanistic
studies of the interactions required for enhanced persistence in vivo
is a critical step towards a more comprehensive understanding of
natural polymicrobial infections. In this study, we used a model
polymicrobial infection [6,7] to determine the importance of
metabolic cross-feeding for establishing co-culture infections.
Cross-feeding in polymicrobial populations has been reported in
numerous studies [24,41,42], but its importance for establishing
co-culture infections has not been investigated in depth. The
methodology used in this study began with detailed studies of the
metabolic pathways required for growth with the in vivo carbon
sources glucose and L-lactate, followed by examination of the
importance of specific catabolic pathways for establishing co-
culture infections.
It is relevant to discuss the rationale for two in vivo experimental
parameters: using a ‘smooth’ strain of A. actinomycetemcomitans in
lieu of a ‘rough’ strain; and using a murine abscess model in lieu of
a rat periodontal infection model [43,44]. A ‘‘smooth’’ strain of A.
actinomycetemcomitans, which displays impaired surface attachment,
was used in this study [45,46]. As we were not investigating
attachment or biofilm development, we opted to utilize a smooth
strain that had undergone robust metabolic characterization, and
feel this decision is justified as this bacterium clearly causes abscess
infections in this model (Fig. 4). The murine abscess model was
used for several reasons. First, in addition to periodontal infections,
A. actinomycetemcomitans causes abscess infections outside of the oral
cavity that resemble, from a gross morphological standpoint, the
abscess model infection [34]; thus the abscess model has clinical
relevance. Second, the abscess model avoids complications arising
from the normal flora, which are not completely eradicated in the
periodontal rat infection models, and whose presence would make
Figure 4. Persistence of A. actinomycetemcomitans, A. actinomy-
cetemcomitans lctD
-,a n dA. actinomycetemcomitans apiA
- in
mono- or co-culture in a murine abscess model. A. Bacterial
colony forming units per abscess. Wilcoxon signed-rank test values are:
*p ,0.02, ** p,0.01, *** p,0.008. B. Abscess weights 6 days post-
inoculation. Error bars represent 1 standard error of the mean, n=9.
p,0.05 for wt A. actinomycetemcomitans in mono- and co-culture via
Student’s t-test.
doi:10.1371/journal.ppat.1002012.g004
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Third, the abscess model allows direct, controlled inoculation with
a finite number of cells that can be quantified throughout the
infection by assessing colony forming units after removal of the
entire abscess [37,47,48]. Finally, although the abscess model has
primarily been used to study anaerobic pathogens [35,36], it is also
relevant for studying aerobic pathogens, demonstrated by the large
abscesses [48] formed by the strict aerobe Acinetobacter baumanii
[17,49]. The presence of aerobic microenvironments in the abscess
is also supported by our observations that the S. gordonii spxB
mutant is significantly impaired for abscess formation (Fig. S2 in
Text S1). The spxB gene encodes pyruvate oxidase which utilizes
O2 for biosynthesis of the virulence factor H2O2 [50]; thus its
importance is limited to aerobic infections.
The observation that A. actinomycetemcomitans requires O2 to
catabolize L-lactate was surprising, as many oral bacteria grow on
L-lactate anaerobically [24,31]. These results also solve an
apparent contradiction in the literature. It was reported by
multiple sources [17,51] that A. actinomycetemcomitans does not
catabolize L-lactate, yet we recently provided evidence that several
strains of A. actinomycetemcomitans grow aerobically with L-lactate as
the sole energy source [6,29]. Interrogation of the previous growth
environments revealed that A. actinomycetemcomitans was grown
under very low or O2 free conditions; thus it is not surprising that
significant growth was not observed in these studies. The O2
dependency of L-lactate oxidation also highlights another facet of
our in vivo data. In the murine abscess model, the A.
actinomycetemcomitans wt and lctD mutant grew equally well in
mono-culture (Fig 4). However, in co-culture only the survival of
the lctD mutant was impaired. This result is reminiscent of our in
vitro data (Fig. 2) suggesting that O2 dependent metabolism occurs
in our model polymicrobial infection.
The observation that the terminal oxidase CydB is required for
aerobic growth with L-lactate allows development of a new model
for L-lactate consumption in A. actinomycetemcomitans (Fig. 5). Since
L-lactate dehydrogenase (LctD) is necessary for lactate oxidation
and does not use NAD
+ as an electron acceptor [29], anaerobic
fermentation pathways that regenerate NAD
+ cannot act as
electron acceptors for L-lactate oxidation. The model predicts that
A. actinomycetemcomitans instead donates electrons directly to the
quinone pool which in turn is re-oxidized by CydAB [52]. It
should be noted that this does not rule out an unknown electron
carrier between LctD and the membrane associated quinone.
The most exciting observation from these studies is that L-
lactate catabolism is likely an important factor for A. actinomyce-
temcomitans to establish a polymicrobial, but not mono-culture,
infection in a murine abscess model (Fig. 4). These data indicate
that host-produced L-lactate is not a vital energy source for A.
actinomycetemcomitans in mono-culture abscesses, but when S. gordonii
is present, L-lactate catabolism becomes critical. We speculate that
in the absence of S. gordonii, carbohydrates such as glucose are
present in the infection site for A. actinomycetemcomitans growth.
When S. gordonii is introduced, competition for these carbohydrates
increases, and A. actinomycetemcomitans is likely at a disadvantage due
to its relatively slow growth and catabolic rates compared to S.
gordonii [6]. Thus, the ability to preferentially utilize L-lactate, the
primary metabolite produced by S. gordonii, allows A. actinomyce-
temcomitans to avoid competition with S. gordonii for carbohydrates
and consequently enhance its survival in the abscess. This model
(Fig. 6) suggests that the importance of individual carbon catabolic
pathways is dependent on the context of the infection, specifically
if oral streptococci are present.
Our work demonstrates that metabolic pathways required for A.
actinomycetemcomitans proliferation during mono-culture infection
are distinct from those required for co-culture infection with a
common commensal. This study provides strong evidence that
simply because elimination of a catabolic pathway does not elicit a
virulence defect in mono-species infection does not preclude it
from being important in polymicrobial infections. Since metabolic
interactions can potentially occur in virtually any polymicrobial
infection, our results suggest that in some cases, the ability to cause
infection will be as dependent on metabolic interactions as it is on
known immune defense mechanisms and classical virulence
factors. Our observations also have therapeutic implications, as
development of small molecule inhibitors of metabolic pathways,
particularly pathways restricted to prokaryotic pathogens, have
promise as new therapeutic targets. Based on this study, efforts to
develop such therapeutics will require a detailed understanding of
how polymicrobial cross-feeding affects colonization and persis-
tence in an infection site.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of Texas Tech University Health Sciences Center
(Protocol Number: 09039).
Strains and media
A. actinomycetemcomitans strains VT1169 [53], Streptococcus gordonii
strain Challis DL1.1 (ATCC 49818), S. gordonii spxB
- [50],
Escherichia coli DH5a-lpir, and E. coli SM10-lpir were used in
this study. A. actinomycetemcomitans and S. gordonii were routinely
cultured using Tryptic Soy Broth + 0.5% Yeast Extract (TSBYE).
For resting cell suspension A. actinomycetemcomitans metabolite
analysis, a Chemically Defined Medium (CDM) [6] lacking
nucleotides, amino acids, pimelate and thioctic acid (to eliminate
further cell growth) containing either 20 mM glucose or 40 mM
L-lactate was used. For co-culture experiments, complete CDM
with 3 mM glucose was used. Aerobic culture conditions were
37uC in a 5% CO2 atmosphere shaking at 165 RPM, and
anaerobic culture conditions were static growth at 37uCi na n
anaerobic chamber (Coy, USA) with a 5% H2, 10% CO2 and
85% N2 atmosphere. E. coli strains were grown on Luria-Bertani
(LB) medium at 37uC. Where applicable, antibiotics were used at
the following concentrations: chloramphenicol, 2 mg/ml for A.
actinomycetemcomitans and 20 mg/ml for E. coli; spectinomycin,
Figure 5. Model for electron transport during L-lactate
oxidation in A. actinomycetemcomitans. A. actinomycetemcomitans
requires O2 for oxidation of L-lactate. LctD may donate electrons from L-
lactate directly to the quinone pool or utilize an unknown intermediate
electron carrier represented by the dotted arrow. The cytochrome
oxidase CydAD ultimately donates the electrons to O2.
doi:10.1371/journal.ppat.1002012.g005
Cross-Feeding in a Polymicrobial Infection
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actinomycetemcomitans and E. coli and 100 mg/ml for selection and
maintenance for S. gordonii spxB
-; kanamycin, 40 mg/ml for
selection and 10 mg/ml for maintenance; naladixic acid, 25 mg/
ml; streptomycin, 50 mg/ml for selection and 20 mg/ml for
maintenance. For quantifying CFU/ml in co-culture assays,
vancomycin (5 mg/ml) was added to agar plates to enumerate A.
actinomycetemcomitans and streptomycin (100 mg/ml) was added to
agar plates to enumerate S. gordonii.
DNA and plasmid manipulations
DNA and plasmid isolations were performed using standard
methods [54]. Restriction endonucleases and DNA modification
enzymes were purchased from New England Biolabs. Chromo-
somal DNA from A. actinomycetemcomitans was isolated using
DNeasy tissue kits (Qiagen), and plasmid isolations were
performed using QIAprep spin miniprep kits (Qiagen). DNA
fragments were purified using QIAquick mini-elute PCR purifi-
cation kits (Qiagen), and PCR was performed using the Expand
Long Template PCR system (Roche). DNA sequencing was
performed by automated sequencing technology using the
University of Texas Institute for Cell and Molecular Biology
sequencing core facility.
A. actinomycetemcomitans apiA mutant construction
Allelic replacement of apiA (AA2485) was carried out by double
homologous recombination. For construction of the knockout
construct, 856 bp and 842 bp DNA fragments flanking apiA were
amplified and combined with the aphA gene (encoding kanamycin
resistance) from pBBR1-MCS2 [55] by overlap extension PCR [56].
The construct was prepared so that aphA was positioned between the
upstream and downstream regions. Primers used were: Kan-59
(ATGTCAGCTACTGGGCTATCTG) and Kan-39 (ATTTC-
GAACCCCAGAGTCCCGC) for the 1074 bp aphA-containing
fragment; ApiA-UF (CCGATAACAGTAAGATCTTCTAC) and
ApiA-UR (CAGATAGCCCAGTAGCTGACATCCTTTTCGG-
CTTGAATTTATACC) for the upstream apiA fragment; and ApiA-
DF (GCGGGACTCTGGGGTTCGAAATGCGGTCAGAATTT-
TAGGTGTTTT) and ApiA-DR (CGAAACCAACGAACTCTT-
TATTC) for the downstream apiA fragment. Underlined sequences
indicate overlapping DNA sequences between the apiA fragments and
aphA. The overlap extension product was TA-cloned into the pGEM-T
Easy vector (Promega, USA) and excised by EcoRI digest. The EcoRI
fragment containing the overlap extension product was ligated into the
unique EcoRI site within the lpir-dependent suicide vector pVT1461
[57]. The cloned construct, pVT1461-apiA-KO, was first transformed
into E. coli DH5a-lpir then into E. coli SM10-lpir for conjugation into
A. actinomycetemcomitans. Conjugation was performed as described [53]
and potential mutants were plated onto TSBYE agar plates containing
kanamycin to select for recombinant A. actinomycetemcomitans and
nalidixic acid to kill the E. coli donors. Kanamycin resistant,
spectinomycinsensitivedoublerecombinantswere selected and verified
by PCR. Enhanced susceptibility of the apiA mutant to serum was
verified as described previously [7].
A. actinomycetemcomitans cydB mutant construction
Insertional mutagenesis of the cydB gene was performed by single
homologous recombination using a 543 bp internal piece of the cydB
(AA2840) gene amplified using the primers cydB-KO59 (GAA-
GATCTTTATGATTAATACTATCGCGCCG) and cydB-KO39
(GAAGATCTCAAAACCATCTTTGAAAGATAACCA). Under-
lined sequences represent BglII restriction sites. The internal cydB
fragment was digested with BglII and ligated into the A.
actinomycetemcomitans suicide vector pMRKO-1 (see below) to generate
pMRKO-cydB. pMRKO-cydB was transformed into E. coli SM10-
lpir and conjugated into A. actinomycetemcomitans. A. actinomycetemcomi-
tans recombinants were grown anaerobically on TSBYE agar
containing spectinomycin and naladixic acid. Colonies were
Figure 6. Model for enhanced persistence of A. actinomycetemcomitans during aerobic co-culture with S. gordonii. During co-culture
aerobic growth with glucose, S. gordonii produces L-lactate and H2O2 which inhibit A. actinomycetemcomitans glucose uptake (red line) and induce
apiA expression (dotted line) respectively. The production of L-lactate provides A. actinomycetemcomitans with a preferred carbon source for growth
and reduces the need to compete with S. gordonii for glucose during aerobic co-culture. During anaerobic co-culture, S. gordonii also produces L-
lactate but A. actinomycetemcomitans is unable to catabolize this carbon source due to the absence of O2; thus requiring A. actinomycetemcomitans
to compete directly with S. gordonii for glucose (dashed line).
doi:10.1371/journal.ppat.1002012.g006
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concentrations and insertion into cydB was verified by PCR.
pMRKO-1 suicide vector construction
The spectinomycin resistance gene from pDMG4 [58] was
amplified by PCR using the primers: 59Spec-cass-NotI (ATAA-
GAATGCGGCCGCCGATTTTCGTTCGTGAATACATG)
and 39 Spec-cass-EcoRI (CGGAATTCCATATGCAAGGGTT-
TATTGTTT), digested with NotI-EcoRI and ligated into NotI-
EcoRI digested pmCherry (Clontech) underlined sequences
indicate NotI and EcoRI restriction sites. The 3105 bp region
containing the pUC origin of replication, plac:mCherry and the
spectinomycin resistance gene were PCR amplified using the
primers: 59pMcher-trunc (GAAGATCTGACCAAGTTTACT-
CATATATACT) and 39 Spec-cass-EcoRI (CGGAATTCCA-
TATGCAAGGGTTTATTGTTT). Underlined sequences indi-
cate BglII and EcoRI restriction sites. This fragment was digested
with BglII and EcoRI and ligated into the 2780 bp fragment from
BglII-EcoRI digested pVT1461. The resulting plasmid (pMRKO-
1, submitted to Genbank) is a suicide vector for A. actinomycetemco-
mitans and contains oriT, mob, and tra genes from pVT1461 along
with the pUC origin of replication, mCherry expressed from plac,
and a spectinomycin resistance cassette.
Resting cell suspensions
A. actinomycetemcomitans was grown in CDM overnight either
aerobically or anaerobically in the presence of 20 mM glucose or
40 mM L-lactate. Bacteria were then subcultured in 30 ml of
medium and exponential phase cells (OD600=0.4) were collected
by centrifugation (5,000 x g for 15 min) at 25uC. Cell pellets were
resuspended in an equal volume of CDM lacking nucleotides,
amino acids and any carbon source. Cells were incubated at 37uC
aerobically or anaerobically depending on the test conditions for
1 hr. Cells were collected again by centrifugation as described
above and resuspended to an OD600 of 2 in 3 ml of CDM without
nucleotides, amino acids, pimelate and thioctic acid containing
either 20 mM glucose or 40 mM lactate. Cells were incubated for
4 h at 37uC either aerobically or anaerobically. After incubation
samples were stored at 220uC for HPLC analysis.
D-Lactate assay
D-lactate assays were performed as described [30] with
modifications. Glycylglycine buffer was replaced with an equal
concentration of Bicine (Fisher, USA) buffer and enzymatic assays
were monitored by spectrophotometry at 340 nm for 4 hours.
Co-culture experiments
A. actinomycetemcomitans and S. gordonii were grown overnight in
CDM containing 3 mM glucose. 3 mM glucose was used to
ensure that the medium was limited for catabolizable carbon. Cells
were diluted 1:50 in the same medium and allowed to grow to
exponential phase (OD600 of 0.2). Cells were then diluted 1:100
(2610
6 S. gordonii/ml and 1610
7 A. actinomycetemcomitans/ml) as
mono-cultures or co-cultures in 3 ml CDM containing 3 mM
glucose. Cultures were allowed to grow for 10 h aerobically or
12 h anaerobically, after which cells were serially diluted, plated
on either TSBYE agar + vancomycin for A. actinomycetemcomitans
enumeration or TSBYE agar + streptomycin for S. gordonii
enumeration. Colonies were counted after incubation at 37uC
for 48 h. An aliquot of the culture was also stored at 220uC for
HPLC metabolite analysis.
HPLC analysis
Metabolite levels were quantified using a Varian HPLC with
a Varian Metacarb 87H 30066.5 mm column at 35uC.
Samples were eluted using isocratic conditions with 0.025 N
H2SO4 elution buffer and a flow rate of 0.5 ml/minute. A
Varian refractive index (RI) detector at 35uCw a su s e df o r
metabolite enumeration by comparison with acetate, ethanol,
formate, glucose, L-lactate, D-lactate, pyruvate and succinate
standards.
In vivo murine abscess growth
Murine abscesses were generated essentially as described
previously [37]. Briefly, 6–8 week-old, female, Swiss Webster
mice were anesthetized with an intraperitoneal injection of
Nembutal (50 mg/kg). The hair on the left inner thigh of each
mouse was shaved, and the skin was disinfected with 70% alcohol.
Mice were injected subcutaneously in the inner thigh with 10
7
CFU A. actinomycetemcomitans, S. gordonii or both. At 6 days post-
infection, mice were euthanized and intact abscesses were
harvested, weighed and placed into 2 ml of sterile PBS (or water
for pH measurements). Tissues were homogenized, serially diluted
and plated on Brain Heart Infusion (BHI) agar + 20 mg/ml
Na2CO3 + vancomycin for A. actinomycetemcomitans enumeration or
BHI agar + 20 mg/ml Na2CO3 + streptomycin for S. gordonii
enumeration, to determine bacterial CFU/abscess. Experimental
protocols involving mice were examined and approved by the
Texas Tech University HSC Institutional Animal Care and Use
Committee.
Supporting Information
Text S1 Figure S1: Growth of S. gordonii in mono- or co-culture
with A. actinomycetemcomitans or A. actinomycetemcomitans lctD
- in
aerobic and anaerobic co-cultures. Strains were grown as mono-
or co-cultures in 3 mM glucose aerobically or anaerobically for 10
or 12 h respectively, serially diluted, and plated on selective media
to determine colony forming units per ml (CFU/ml). S. gordonii
mono-cultures numbers are represented by black bars, co-culture
numbers with A. actinomycetemcomitans are represented by white
bars, and co-culture numbers with A. actinomycetemcomitans lctD
- are
represented by grey bars. Error bars represent 1 standard error of
the mean, n=3. Figure S2: Survival of S. gordonii and S. gordonii
spxB
- in a murine abscess model. A. Number of bacteria recovered
from each abscess expressed as colony forming units per abscess
(CFU/abscess). Wilcoxon signed-rank test value, p,0.03. B.
Abscess weights 6 days post-inoculation. Error bars represent 1
standard error of the mean, n=4.
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